Traws Pharma Statistics Share Statistics Traws Pharma has 4.77M
shares outstanding. The number of shares has increased by 83.92%
in one year.
Shares Outstanding 4.77M Shares Change (YoY) 83.92% Shares Change (QoQ) 10.55% Owned by Institutions (%) 6.84% Shares Floating 3.95M Failed to Deliver (FTD) Shares 450 FTD / Avg. Volume 0.4%
Short Selling Information The latest short interest is 162.9K, so 2.31% of the outstanding
shares have been sold short.
Short Interest 162.9K Short % of Shares Out 2.31% Short % of Float 3.11% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.25 and the forward
PE ratio is -0.09.
Traws Pharma's PEG ratio is
0.
PE Ratio -0.25 Forward PE -0.09 PS Ratio 61.01 Forward PS 30.3 PB Ratio -0.44 P/FCF Ratio -0.46 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Traws Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.16,
with a Debt / Equity ratio of 0.
Current Ratio 2.16 Quick Ratio 2.16 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $37.67K Profits Per Employee $-9.11M Employee Count 6 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -78.15% in the
last 52 weeks. The beta is 1.52, so Traws Pharma's
price volatility has been higher than the market average.
Beta 1.52 52-Week Price Change -78.15% 50-Day Moving Average 1.55 200-Day Moving Average 3.29 Relative Strength Index (RSI) 67.09 Average Volume (20 Days) 111,404
Income Statement In the last 12 months, Traws Pharma had revenue of 226K
and earned -54.67M
in profits. Earnings per share was -35.21.
Revenue 226K Gross Profit 214K Operating Income -49.35M Net Income -54.67M EBITDA -166.51M EBIT -166.52M Earnings Per Share (EPS) -35.21
Full Income Statement Balance Sheet The company has 21.34M in cash and 0 in
debt, giving a net cash position of 21.34M.
Cash & Cash Equivalents 21.34M Total Debt n/a Net Cash n/a Retained Earnings -649.15M Total Assets 15.62M Working Capital 8.02M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -29.79M
and capital expenditures 0, giving a free cash flow of -29.79M.
Operating Cash Flow -29.79M Capital Expenditures n/a Free Cash Flow -29.79M FCF Per Share -19.19
Full Cash Flow Statement Margins Gross margin is 94.69%, with operating and profit margins of -21835.4% and -24192.04%.
Gross Margin 94.69% Operating Margin -21835.4% Pretax Margin -73682.74% Profit Margin -24192.04% EBITDA Margin -73677.43% EBIT Margin -21835.4% FCF Margin -13182.3%
Dividends & Yields TRAW does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for TRAW.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 23, 2024. It was a
backward
split with a ratio of 1:25.
Last Split Date Sep 23, 2024 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -58.69 Piotroski F-Score 5
